This post was originally published on this site
Omicron contains more than 30 mutations to its spike protein, and the effectiveness of existing vaccines may be lower. Scientists in South Africa are now exploring omicron. Also, vaccine makers have already started working on boosters to address the omicron variant, and a new omicron-specific vaccine could be ready in the near term.
Given this backdrop, we believe fundamentally sound vaccine stocks Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) could be solid bets now.
